Literature DB >> 32705125

Comment on: Cytopenias among patients with rheumatic diseases using methotrexate: a meta-analysis of randomized controlled clinical trials: reply.

Kathleen M M Vanni1, Daniel H Solomon1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32705125      PMCID： PMC7824992          DOI： 10.1093/rheumatology/keaa290

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  3 in total

1.  Comment on: Cytopenias among patients with rheumatic diseases using methotrexate: a meta-analysis of randomized controlled clinical trials.

Authors:  Kieran E Murray; Matthew A Turk; Douglas J Veale
Journal:  Rheumatology (Oxford)       Date:  2020-10-01       Impact factor: 7.580

2.  Adverse Effects of Low-Dose Methotrexate: A Randomized Trial.

Authors:  Daniel H Solomon; Robert J Glynn; Elizabeth W Karlson; Fengxin Lu; Cassandra Corrigan; Josh Colls; Chang Xu; Jean MacFadyen; Medha Barbhaiya; Nancy Berliner; Paul F Dellaripa; Brendan M Everett; Aruna D Pradhan; Sarah P Hammond; Meredith Murray; Deepak A Rao; Susan Y Ritter; Anna Rutherford; Jeffrey A Sparks; Jackie Stratton; Dong H Suh; Sara K Tedeschi; Kathleen M M Vanni; Nina P Paynter; Paul M Ridker
Journal:  Ann Intern Med       Date:  2020-02-18       Impact factor: 25.391

Review 3.  Cytopenias among patients with rheumatic diseases using methotrexate: a meta-analysis of randomized controlled clinical trials.

Authors:  Kathleen M M Vanni; Houchen Lyu; Daniel H Solomon
Journal:  Rheumatology (Oxford)       Date:  2020-04-01       Impact factor: 7.580
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.